Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Coala Life November monthly KPI´s USA

Coala-Life Group

KPI´s November 2023:
- Patients in RPM as of November 30, 2023: 3,800
- Annual revenue rate as of November 30, 2023: $3.7 million
 
Explanations of KPI´s
Patients in RPM as of November 30, 2023 – Number of patients that the company monitors in USA at the end of November.
Annual revenue rate as of November 30, 2023 – Estimated recurring revenue in USD based on November month´s revenue, measured at an annual rate.
 
Comments of KPI´s November 2023
November was with the holidays one week shorter than October, at the same time during the month Coala ended its collaboration with about 10 clinics that turned out to be poor payers. With a good pipeline, we believe this will be compensated for in Q1 2024.
 

Historical KPI´s
 

MonthPatients in remote monitoringAnnual rate of turnover
November 20233,8003.7 MUSD
October 20234,4004.6 MUSD
September 20234,4005.0 MUSD
Augusti 20234,4005.2 MUSD
Juli 20234,1005.0 MUSD
Juni 20234,1005.6 MUSD
Maj 20233,8005.7 MUSD
April 20233,7005.4 MUSD
Mars 20233,7004.8 MUSD
Februari 20233,7004.6 MUSD
Januari 20233,8003.7 MUSD
December 20223,5003.6 MUSD
November 20223,1003.2 MUSD
Oktober 20222,8003.2 MUSD
September 20222,6002.7 MUSD


The figures in this press release are preliminary and unaudited.

About us


Coala-Life Group AB (“Coala Life” or the “Company”) founded in 2015, is a Cloud Based Software as a Service provider, and medical device developer and reseller, listed on Nasdaq First North Growth Market. The Company focuses on B2B solutions for managed Remote Patient Monitoring (“RPM”), offering medical care providers, primarily in the US, with a highly scalable, cost-efficient platform to remotely and virtually manage large volumes of patients suffering from chronic diseases. The company offers care providers a comprehensive solution and lifts the administrative work from the care providers regarding, amongst other things, follow-up, 24/7 monitoring, as well as the reimbursement process from state and private health insurance companies. Patients are monitored long-term in everyday life and typically have diabetes, obesity, and/or cardiovascular disease. 
For more information see www.coalalife.com

For more information, please contact:


Dan Pitulia, CEO Coala Life AB
+44 7849 257 532, dan.pitulia@coalalife.com
Robin Danielsson Källmark, Interim CFO Coala Life AB
+46 72 188 84 09, robin.danielsson.kallmark@coalalife.com

Certified Adviser
The Company’s Certified Adviser is Carnegie Investment Bank AB (publ).

Attachments


Coala Life November monthly KPI´s USA

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.